---
up: 
down: 
related: 
tags: []
aliases:
  - ANZCA.BT_PM 1.15
type: "[[LO.C.PEX.ANZCA]]"
order:
  - "[[Discuss]]"
field:
  - "[[Clinical Implications]]"
  - "[[Opioids]]"
  - "[[Pain Pharmacology]]"
  - "[[Pharmacokinetics]]"
  - "[[Pharmacology]]"
dg-publish: true
title: ANZCA.12.3.2.4_BT_PM.1.15_Opioids_Pharmacokinetics_Clinical_Implications_Routes
date created: Thursday, March 6th 2025, 12:41:23
date modified: Tuesday, March 25th 2025, 16:09:22
---

[[Discuss]] the [[pharmacokinetic]] and [[clinical implications]] of [[different routes of administration]] for [[commonly used opioids]], including the [[oral route|oral]], [[transdermal route|transdermal]], [[subcutaneous route|subcutaneous]], [[intramuscular route|intramuscular]] and [[intravenous route|intravenous routes]] (including [[Patient Controlled Analgesia - PCA|Patient Controlled Analgesia - PCA]]).
